3
Events
24 November, 2021

Assessing public contributions to drug development: a novel framework

Global Health Centre
3
Events
16–17 November 2023

Introduction to Innovation & Access to Medicines in Global Health

Maison de la Paix
Global Health Centre
310
News
22nd June 2021

WHO Global Evidence Review on Health and Migration

Global Migration Centre
3
Events
3 December, 2018

The Overlapping Crises of Democracy, Globalisation and Global Governance – what does it mean for global health?

Maison de la Paix
Global Health Centre
3
Publications
Report, 2019

Health a political choice: delivering universal health coverage 2030

Ilona Kickbusch
3
Events
8 May, 2023

Using financial analysis to unpack drug development trajectories

Maison de la Paix
Global Health Centre
316
Events
8 April, 2022

The Global Challenge of Governing Pandemics

Suerie Moon and Global Health Centre
Events
11–12 December 2019

From Science to Practice: Strengthening Research Uptake to Achieve the SDGs

World Meteorological Organization (WMO)
Global Governance Centre, Thomas Biersteker and Velibor Jakovleski
3
News
11th July 2022

WHO and I-DAIR to Partner for International Research in Artificial Intelligence (AI) and Digital Health

Global Health Centre
3
News
7th May 2021

A pandemic treaty for a fragmented global polity

Suerie Moon, Ilona Kickbusch and Global Health Centre
3
Events
28 February, 2022

Covid-19 and reframing the discourse on global health equity: Challenges, trade-offs and opportunities

Global Health Centre
3
Events
27 October, 2020

Incentives to Increase the Use of Tracing and Testing Apps: Carrots or Sticks?

Global Health Centre
Close

Goal 3 seeks to “ensure health and well-being for all, at every stage of life. The Goal addresses all major health priorities, including reproductive, maternal and child health; communicable, non-communicable and environmental diseases; universal health coverage; and access for all to safe, effective, quality and affordable medicines and vaccines. It also calls for more research and development, increased health financing, and strengthened capacity of all countries in health risk reduction and management” as the UN Sustainable Development Knowledge Platform highlights. Read more about Goal 3.

Close
Target 3.1

By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births

Target 3.2

By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births

Target 3.3

By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases

Target 3.4

By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being

Target 3.5

Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol

Target 3.6

By 2020, halve the number of global deaths and injuries from road traffic accidents

Target 3.7

By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes

Target 3.8

Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all

Target 3.9

By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination

Target 3.a

Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate

Target 3.b

Support the research and development of vaccines and medicines for the communicable and noncommunicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all

Target 3.c

Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States

Target 3.d

Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks